PT  - JOURNAL ARTICLE
AU  - Fahim, Christine
AU  - Hassan, Ayaat T.
AU  - Quinn de Launay, Keelia
AU  - Takaoka, Alyson
AU  - Togo, Elikem
AU  - Strifler, Lisa
AU  - Bach, Vanessa
AU  - Paul, Nimitha
AU  - Mrazovac, Ana
AU  - Firman, Jessica
AU  - Gruppuso, Vincenza
AU  - Boyd, Jamie M.
AU  - Straus, Sharon
TI  - Challenges facing Canadian Long-Term Care Homes and Retirement Homes during the COVID-19 pandemic
AID  - 10.1101/2024.06.19.24308949
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.06.19.24308949
4099  - http://medrxiv.org/content/early/2024/06/24/2024.06.19.24308949.short
4100  - http://medrxiv.org/content/early/2024/06/24/2024.06.19.24308949.full
AB  - COVID-19 presented a crisis for long-term care homes (LTCHs) and retirement homes (RHs). This study explored the pandemic-related challenges LTCHs and RHs faced and the strategies they used to mitigate them. Ninety-one key informant interviews were conducted with LTCH and RH leadership across 47 homes (33 LTCHs, 14 RHs) in Ontario, Canada from February 2021 to July 2022. Findings confirmed evidence for three main challenges. First, leaders were challenged to implement infection prevention and control protocols and measures. Second, they needed supports to facilitate COVID-19 vaccine access and to promote vaccine confidence. Third, LTCH/RH staff experienced significant well-being challenges in the face of COVID-19 pressures. Findings also reveal a plethora of strategies implemented by homes, with ranging reports of perceived success. Homes’ needs evolved rapidly as the COVID-19 pandemic progressed. The use of a co-creation, responsive and tailored approach to address evolving barriers and meaningfully support homes during emergencies is recommended.Key pointsCOVID-19 challenges in homes persisted over one year into the pandemicWe describe the IPAC, vaccine and wellness challenges faced by LTCH and RHWe used these data to design a congregate care home support program to navigate COVID-19 challengesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the COVID-19 Immunity Task Force under Grant #2021-HQ-000143Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Unity Health Toronto gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors